kw1986 schreef op 10 december 2020 10:48:
[...]
Development of an antibody lateral flow test for COVID-19
On 29 September 2020, Novacyt announced the launch of its IgG specific antibody test
for use in central laboratory testing. The Company is also working on developing an IgG
antibody lateral flow test (LFT) for use as a rapid antibody test for professional use. An
LFT is an easy-to-use diagnostic device used to confirm the presence or absence of a
pathogen or biomarker. The product is expected to launch during Q1 2021 and is expected
to take approximately 20 minutes or less to give a result.